Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 1/2 2Phase NA 1Phase 4 1Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Osteoradionecrosis 1Obesity 1Neoplasms 1Mouth Neoplasms 1Metastasising Cancer of Unknown Primary 1Invasive Breast Cancer 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Neuroendocrine Tumor G1 1Coronary Artery Disease 1Colorectal Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Medroxyprogesterone Acetate 3semaglutide 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1fluciclovine F-18 1ferrous gluconate 1dostarlimab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Resistance Training 1Progestins 1Observation 1Nutrition Assessment 1Metformin 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1LY 353381 1Indocyanine Green 1Hysteroscopy 1High-Energy Shock Waves 1Estrogen Replacement Therapy 1Biomarkers 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endometrial Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡